+ Watch MNKD
on My Watchlist
A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer.
So ... tired ... of ... talking ... about ... MannKind ...There's still lots of KoolAid left in the jug.
So ... tired ... of ... you...talking ... about ... KoolAid...and...MannKind ...But you do make for a bit of comic relief with your flips and flops on the same companies! I guess when you aim for a few more points it makes sense? Do you actually buy and sell real shares everytime you flip opinion?
Here's a link to help you get some of your money back:http://finance.yahoo.com/news/Glancy-Binkow-Goldberg-LLP-bw-1562794808.html?x=0
I know, I know... These ambulance chasers come out to say risk wasn't understood when the FDA says no to biotech companies. Some fools believe these lawsuits and it scares of a few I guess? As if investing in binary biotech companies with single products isn't risky! I'm sure these lawsuit will go far...I'm still buying shares! As with so many other baby biotechs: we don't agree about Mannkind. From what I can tell you invest using momentum. I buy what I think will do well long term and don't sell very much. Time will tell.Cheers,Jean Pierre
Wow...this thing is taking quite the beating. Are you considering it for a GBMB entry?
Mannkind is unlikely to be a GBMB stock simply because there is no identifiable bottom. There's no pipeline other than Afrezza and a mountain of debt. Mann either proceeds or pulls the plug, in which case the share price goes to 0. Unless you know him well enough to hear him talk in his sleep, it's a dice roll.
The FDA approved methampethamine for kids, but not a drug with controlled studies that would mean thousands of people would no longer have to use needles everyday. Go figure.Here is the meth drug on the market. Go get some:http://www.rxlist.com/desoxyn-drug.htm
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions